Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

(MM) (DNDN)

(MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DNDN
DateTimeSourceHeadlineSymbolCompany
22/02/201021:00PR Newswire (US)Dendreon Reports Fourth Quarter and 2009 Year End Financial ResultsNASDAQ:DNDNN^CURN
11/02/201022:00PR Newswire (US)Dendreon to Host Conference Call on February 22 to Announce Fourth Quarter and Full Year 2009 ResultsNASDAQ:DNDN
03/02/201012:30PR Newswire (US)Dendreon Announces Webcast Presentation at 12th Annual BIO CEO and Investor ConferenceNASDAQ:DNDN
05/01/201012:30PR Newswire (US)Dendreon Announces Webcast Presentation at 28th Annual J.P. Morgan Healthcare ConferenceNASDAQ:DNDN
11/12/200923:13PR Newswire (US)Dendreon Announces Exercise of Option by Underwriters in its Common Stock OfferingNASDAQ:DNDN
11/12/200900:48PR Newswire (US)Dendreon Announces Pricing of Common Stock OfferingNASDAQ:DNDN
10/12/200911:30PR Newswire (US)Dendreon Appoints Hans Bishop as Chief Operating OfficerNASDAQ:DNDN
08/12/200922:09PR Newswire (US)Dendreon Announces Proposed Public Offering of Common StockNASDAQ:DNDN
25/11/200912:30PR Newswire (US)Dendreon Announces Webcast Presentations at Upcoming Investor ConferencesNASDAQ:DNDN
20/11/200913:30PR Newswire (US)Dendreon Receives FDA Acknowledgement of Complete ResponseNASDAQ:DNDN
11/11/200921:00PR Newswire (US)Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE CommercializationNASDAQ:DNDN
02/11/200913:30PR Newswire (US)Dendreon Completes Submission of Biologics License Application for PROVENGENASDAQ:DNDN
30/10/200911:30PR Newswire (US)Dendreon to Hold Conference Call on Wednesday, November 11, 2009 at 4:30 PM ETNASDAQ:DNDN
29/10/200911:30PR Newswire (US)Dendreon Announces Webcast Presentations at Upcoming Investor ConferencesNASDAQ:DNDN
12/10/200917:59PR Newswire (US)Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of DirectorsNASDAQ:DNDN
24/09/200917:51Dow Jones News2nd UPDATE: Dendreon Says Provenge Launch, Filing On TrackNASDAQ:DNDNDendreon Corp.
24/09/200916:30Dow Jones NewsUPDATE:Dendreon Sees Up To $2.5 Billion In Provenge Revenue If OK'dNASDAQ:DNDNDendreon Corp.
24/09/200914:54Dow Jones NewsDendreon Expects To File For Provenge Marketing Approval In Mid-NovNASDAQ:DNDNDendreon Corp.
04/09/200922:43PR Newswire (US)Dendreon Announces Webcast Presentations at Upcoming Investor ConferencesNASDAQ:DNDN
27/08/200912:30PR Newswire (US)Dendreon Announces Analyst Day Webcast Presentation to be Held on September 24, 2009NASDAQ:DNDN
11/08/200912:00PR Newswire (US)Dendreon Reports Second Quarter 2009 Financial ResultsNASDAQ:DNDN
30/07/200912:30PR Newswire (US)Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ETNASDAQ:DNDN
05/06/200912:30PR Newswire (US)Dendreon Announces Webcast Presentations at Upcoming Investor ConferencesNASDAQ:DNDN
14/05/200912:30PR Newswire (US)Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the PacifNASDAQ:DNDN
13/05/200916:08PR Newswire (US)Dendreon Announces Closing of Common Stock OfferingNASDAQ:DNDN
08/05/200911:30PR Newswire (US)Dendreon Announces Common Stock OfferingNASDAQ:DNDN
07/05/200912:30PR Newswire (US)Dendreon Announces Webcast Presentations at Upcoming Investor ConferencesNASDAQ:DNDN
06/05/200912:30PR Newswire (US)Dendreon Reports First Quarter 2009 Financial ResultsNASDAQ:DNDN
30/04/200915:37PR Newswire (US)TryPennyStocks.com Issues Hot Stocks On The Move Today: WFC, BRCD, DNDN, GS, FITB, MS, ETFCNASDAQ:DNDN
29/04/200918:36Dow Jones NewsDendreon Drug Clears Difficult Hurdle, But Others RemainNASDAQ:DNDNDendreon Corp.
 Showing the most relevant articles for your search:NASDAQ:DNDN